Licensing

Hikma to acquire Canadian assets of Teligent
The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.
U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent
Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years.

New York Gov. Hochul signs legislation bringing regulatory structure to PBMs

The bill sets forth duties and obligations that PBMs must follow when performing services.
‘We’ not ‘me:’ Putting turf aside for better patient care

Pharmacy Quality Alliance’s CEO emphasizes a collaborative, team-based approach to dispensing medications.
Richter, Hikma ink deal for proposed biosimilars Prolia, Xgeva

Prolia and Xgeva are used to treat osteoporosis and fractures due to bone metastasis respectively.
APhA names Remington Honor Medal recipient

Peter Harris Vlasses, recipient of the award, serves as the executive director emeritus of the Accreditation Council for Pharmacy Education.
ANI secures FTC clearance to acquire Novitium

The acquisition is expected to be completed on or about Nov. 18.
FSD Pharma inks deal with Covar for development of Lucid-PSYCH

FSD Pharma has entered into an agreement with Covar Pharmaceuticals to commence work on providing research quantities of FSD’s drug candidate, Lucid-PSYCH.
PTCB launches point-of-care testing credential for pharmacy technicians

Technicians who earn the PTCB Point-of-Care Testing Certificate demonstrate their advanced knowledge in screening patients, administering tests, collecting specimens, and reading and recording test results.
Kinney Drugs appoints John Marraffa president

Marraffa, a former Walgreens executive, joined KPH Healthcare Services in 2019 as vice president of government affairs and healthcare services integration.

Hikma to acquire Canadian assets of Teligent

U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent

New York Gov. Hochul signs legislation bringing regulatory structure to PBMs

‘We’ not ‘me:’ Putting turf aside for better patient care

Richter, Hikma ink deal for proposed biosimilars Prolia, Xgeva

APhA names Remington Honor Medal recipient

ANI secures FTC clearance to acquire Novitium

FSD Pharma inks deal with Covar for development of Lucid-PSYCH

PTCB launches point-of-care testing credential for pharmacy technicians

Kinney Drugs appoints John Marraffa president